e-learning
resources
Glasgow 2004
Monday 06.09.2004
Problems of resistance and HIV coinfection in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of the multidrug resistant TB in children with HIV infection
M. Gheorghe, M. Rodica, M. Mariana, M. Olga, M. Constantin (Bucharest, Romania)
Source:
Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Session:
Problems of resistance and HIV coinfection in tuberculosis
Session type:
Oral Presentation
Number:
2712
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gheorghe, M. Rodica, M. Mariana, M. Olga, M. Constantin (Bucharest, Romania). Evaluation of the multidrug resistant TB in children with HIV infection. Eur Respir J 2004; 24: Suppl. 48, 2712
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Multidrug resistant tuberculosis in non HIV patients
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020
Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients
Source: Eur Respir J 2004; 24: Suppl. 48, 650s
Year: 2004
Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection.
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
Multidrug-resistant TB in children with HIV infection in Romania
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Collapsotherapy of multi-drug resistant TB in prisoners
Source: Eur Respir J 2003; 22: Suppl. 45, 522s
Year: 2003
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004
Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Rapid diagnosis of bacterial co-infection and antimicrobial resistance in patients with SARS-Cov-2 infection
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021
Outcomes of patients with multidrug resistant tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
Risk factors for multi-drug resistant TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Burden of the primary drug resistance of Mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
Multi drug resistant (rifampicin + isoniazid) pulmonary tuberculosis – a challenge for a developing country specially co-infected with HIV
Source: Eur Respir J 2007; 30: Suppl. 51, 421s
Year: 2007
Our experience in multi drug resistant tuberculosis (MDR TB) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept